Omega-3 Fatty Acids Plus Vitamin E Cosupplementation Versus Vitamin E in Fibrocystic Breast Patient

Cairo University120 enrolled

Overview

to identify the effect of omega-3 plus vitamin E cosupplementation on mastalgia in patients with FCC and to compare its effect with that of vitamin E only.

120 patients will be enrolled in the study and divided into three groups each group consisted 40 patient then the severity of mastalgia in the three groups before, through and after intervention. Radiological assessment was done before and after the intervention.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

120

Conditions

Mastalgia

Interventions

Omega 3 fatty acidDRUG

omega 3 1000 mg

VitaEDRUG

vitamin e 400 mg

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all females with mastalgia aged 18 to 55 Exclusion Criteria: Pregnant and lactating women, patient who had a recent breast abscess or breast drainage, patient used omega-3 and vitamin E supplementation before the trial and postmenopausal women. \-

Locations (1)

Rehab Sabry

Cairo, Muslim, Egypt

Outcomes

Primary Outcomes

improvement of pain severity

improvement of pain on visual analogue scale

Time frame: 3 months

Secondary Outcomes

improvement of radiological finding

Time frame: 3 months

Central Contacts

Rehab Sabry

CONTACT

0201063314476 rehab.yassen@kasralainy.edu.eg

Heba El nahas

CONTACT

020104810684 hebagalal@kasralainy.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.